|
2,123
|
| 17585 |
P. aeruginosa infection
|
|
increases_quantity of
|
Pyoverdine I
|
|
| 17589 |
Pyoverdine I
|
|
increases_expression of
|
toxA
|
|
| 17590 |
Pyoverdine I
|
|
increases_expression of
|
prpL
|
|
| 17591 |
Pyoverdine I
|
|
affects_quantity of
|
Pyoverdine I
|
|
| 24227 |
Pyoverdine I
|
|
increases_activity of
|
iron assimilation
|
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
|
2,251
|
| 19221 |
pvdS
|
|
affects_quantity of
|
Pyoverdine I
|
|
| 19222 |
pvdA
|
|
affects_quantity of
|
Pyoverdine I
|
|
| 19223 |
pvdE
|
|
increases_quantity of
|
Pyoverdine I
|
|
|
17254955
|
Pseudomonas aeruginosa diseases
|
|
2,285
|
| 19514 |
lasR
|
|
increases_quantity of
|
Pyoverdine I
|
|
| 19592 |
ppyR
|
|
increases_quantity of
|
Pyoverdine I
|
|
|
20738404
|
Pseudomonas aeruginosa diseases
|
|
2,521
|
| 23503 |
lipA
|
|
increases_quantity of
|
Pyoverdine I
|
under iron-limitation conditions
|
|
21840975
|
Pseudomonas aeruginosa diseases
|
|
2,536
|
| 23624 |
pvdS
|
|
affects_quantity of
|
Pyoverdine I
|
|
| 23631 |
cysB
|
|
increases_quantity of
|
Pyoverdine I
|
|
|
20370820
|
Pseudomonas aeruginosa diseases
|
|
2,932
|
| 26807 |
2-Amino acetophenone, 2-AA
|
|
decreases_quantity of
|
Pyoverdine I
|
|
|
21829370
|
Pseudomonas aeruginosa diseases
|
|
3,077
|
| 28281 |
fpvA
|
|
increases_transport of
|
Pyoverdine I
|
|
| 28284 |
pvdN
|
|
increases_quantity of
|
Pyoverdine I
|
|
|
16621825
|
Pseudomonas aeruginosa diseases
|
|
3,277
|
| 30190 |
Pyoverdine I
|
|
increases_activity of
|
biofilm formation
|
|
|
20352420
|
Pseudomonas aeruginosa diseases
|
|
3,299
|
| 30309 |
pvdRT-opmQ efflux complex
|
|
increases_transport of
|
Pyoverdine I
|
from the periplasm to the extracellular milieu
|
| 30313 |
fpvA
|
|
increases_transport of
|
Pyoverdine I
|
of ferri-PVD (pyoverdine) into the periplasmic space
|
| 30314 |
mexAB-oprM multidrug efflux complex
|
NOT |
affects transport of
|
Pyoverdine I
|
|
| 30315 |
pvdE
|
|
affects transport of
|
Pyoverdine I
|
of the nonfluorescent PVD precursor ferribactin from the cytosol to the periplasm
|
|
19906986
|
Pseudomonas aeruginosa diseases
|
|
3,585
|
| 33552 |
pvdQ
|
|
affects_quantity of
|
Pyoverdine I
|
|
|
18245294
|
Pseudomonas aeruginosa diseases
|
|
3,858
|
| 38758 |
pvdE
|
|
increases_quantity of
|
Pyoverdine I
|
|
|
22080193
|
Pseudomonas aeruginosa diseases
|
|
4,337
|
| 44381 |
P. aeruginosa infection, chronic
|
|
affects_quantity of
|
Pyoverdine I
|
in sputum of most but not all CF patients
|
| 44387 |
pvdS
|
|
affects_quantity of
|
Pyoverdine I
|
|
| 44389 |
pvdH
|
|
affects_quantity of
|
Pyoverdine I
|
|
| 44390 |
pvdL
|
|
affects_quantity of
|
Pyoverdine I
|
|
|
23690396
|
Pseudomonas aeruginosa diseases
|
|
5,009
|
| 49422 |
rsmA
|
|
decreases_quantity of
|
Pyoverdine I
|
under iron-depleted conditions
|
|
23796404
|
Pseudomonas aeruginosa diseases
|
HoPaCI